New mRNA Flu Vaccine Produced Much Higher Rates of Adverse Reactions Than Standard Shot

John Campbell, Ph.D., said Moderna’s clinical trial reported substantially higher rates of adverse reactions among people who received its new mRNA flu vaccine than among those who received a standard flu vaccine.